What is FloSpine?
Founded in March 2011, FloSpine is a privately held company dedicated to developing proprietary, innovative spine implants and instruments. The company's core strategy revolves around applying novel technology and design concepts to address complex medical challenges within the human spinal column. FloSpine aims to equip surgeons with advanced products that enhance surgical outcomes, reduce hospital stays, and accelerate patient recovery times, thereby lowering overall procedural and rehabilitative costs for patients and insurers. The primary customers are physicians and the distributors who support them.
How much funding has FloSpine raised?
FloSpine has raised a total of $1.5M across 2 funding rounds:
Other Financing Round
$1M
Angel/Seed
$530K
Other Financing Round (2022): $1M, investors not publicly disclosed
Angel/Seed (2024): $530K, investors not publicly disclosed
What's next for FloSpine?
The recent major strategic investment signals a pivotal growth phase for FloSpine, likely enabling the company to scale its operations, expand its product development pipeline, and broaden its market reach. This enterprise-level funding suggests confidence from investors in FloSpine's technology and its potential to capture a significant share of the spine implant market. Future initiatives may include further clinical validation, strategic partnerships, and enhanced sales and marketing efforts to solidify its position as a key innovator in spinal solutions.
See full FloSpine company page
